COSCIENS Biopharma Inc. (CSCI) — Capital Reinvestment Ratio
Latest as of September 2023:
0.06x
COSCIENS Biopharma Inc. (CSCI) has a Capital Reinvestment Ratio of 0.06x as of September 2023, meaning it reinvests 0% of its operating cash flow ($144.00K) in capital expenditures ($8.92K). See COSCIENS Biopharma Inc. free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.06x
Capex / Operating Cash Flow
Operating Cash Flow
$144.00K
USD
Capital Expenditures
$8.92K
USD
Data as of
Sep 2023
Most recent filing
COSCIENS Biopharma Inc. Capital Reinvestment Ratio (2003–2022)
This chart tracks COSCIENS Biopharma Inc.'s Capital Reinvestment Ratio across 13 annual periods.
Annual Capital Reinvestment Ratio for COSCIENS Biopharma Inc. (2003–2022)
Year-by-year Capital Reinvestment Ratio for COSCIENS Biopharma Inc. from 2003 to 2022. For live market cap and broader valuation context, see market cap of COSCIENS Biopharma Inc..
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.00x | $5.23 Million | $10.57K | ▼ -99.0% |
| 2021 | 0.20x | $2.75 Million | $555.99K | ▲ +45.3% |
| 2020 | 0.14x | $3.49 Million | $485.46K | ▲ +2689786.0% |
| 2019 | 0.00x | $675.29K | $3.49 | ▼ -100.0% |
| 2017 | 2.55x | $1.25 Million | $3.20 Million | ▲ +150.5% |
| 2016 | 1.02x | $3.63 Million | $3.71 Million | ▼ -3.5% |
| 2015 | 1.06x | $2.87 Million | $3.03 Million | ▼ -51.2% |
| 2014 | 2.16x | $1.84 Million | $3.98 Million | ▼ -54.0% |
| 2013 | 4.70x | $460.21K | $2.16 Million | ▲ +2917.9% |
| 2011 | 0.16x | $791.62K | $123.30K | ▼ -12.1% |
| 2010 | 0.18x | $479.50K | $85.01K | ▼ -62.7% |
| 2006 | 0.47x | $140.59K | $66.73K | ▼ -74.9% |
| 2003 | 1.89x | $54.42K | $103.05K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow